Mayo Clinic
Rochester, Minnesota, 55901, United States
NCT Number: NCT00588939
Heartburn or reflux disease affects about 20% of Americans. 50 - 70% of people who have endoscopy for reflux disease have a normal appearing esophagus. Confocal Laser Microscopy allows us to see changes in the cells not visable during routine endoscopy. Whe goal of this study is to identify the use of this new technique in diagnosing reflux in patients who have normal appearing esophagus.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Rochester, Minnesota, 55901, United States
Gastroesophageal reflux disease (GERD) remains a major problem in the United States affecting about 20% of Americans. Upper endoscopy (EGD) is commonly used to diagnose and grade GERD based on mucosal breaks and erosions. It is now evident from multiple studies however that the majority of GERD patients (50-70%) have negative EGDs.These patients are refered to as "Non Erosive Reflux Disease" (NERD) patients.Confocal Laser Microscopy (CLM) is a new endoscopic technique that offers the advantage of detecting histologic changes during real time endoscopy and thus can diagnose NERD. We thus propose to study the sensitivity and specificity of CLM in predicting NERD. We hypothesize that CLM can reliably diagnose NERD in the appropriate clinical setting based on intrapapillary capillary loop patterns. This will be a pilot study after which a randomized trial will evaluate the reversibility of these changes after PPI therapy as seen by CLM
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
completed during endoscopy
Other names: Mauna Kea Cellvizeo
Time frame: at time of procedure
Time frame: at time of procedure
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00703534
Acid Reflux Disease, Deglutition Disorders
Athens, Alabama, United States
View Trial DetailsNCT00998244
Acid Reflux Disease, Body Weight
Chapel Hill, North Carolina, United States
View Trial DetailsNCT00307944
Acid Reflux Disease, Apnea
Cincinnati, Ohio, United States
View Trial DetailsNCT07379645
Deglutition Disorders, Digestive System Diseases
San Francisco, California, United States
View Trial Details